European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Fresenius SE & Co. KGaA, Bad Homburg v. d. Höhe, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Fresenius SE & Co. KGaA

Register

Ut
District Court of Bad Homburg HRB 11852
Stockp
FRE.DE
Stockp
FSNUF
Stockp
FSNUY
Stockp
FRE.SW
Lei
XDFJ0CYCOO1FXRFTQS51

Address

Else-Kröner-Str. 1, 61352 Bad Homburg v. d. Höhe, Germany

Corporate purpose

(a) the development, manufacture, distribution and trade in health care products, systems and processes; (b) the establishment, construction and operation of medical and curative facilities and hospitals; (c) medical and pharmaceutical advice and scientific information and documentation.

Financials

History

Legal Representatives

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

10 Jul 2023
Annual report for the year ending 31/12/2022
3 Jul 2023 also 08/05/2023, 03/02/2011
Shareholder (1)
15 Jun 2023
Company statute
19 May 2023
Dividendenbekanntmachung
15 May 2023
Annual report
26 Apr 2023
Officer: Alexandra Barallon, Andreas Nenner
5 Apr 2023
Annual report for the year ending 31/12/2022
30 Mar 2023
Einladung zur Ordentlichen Hauptversammlung
21 Mar 2023
Shareholder: Amundi SA
20 Mar 2023
Officer: Tobias Greven
7 Feb 2023
Officer: Dennis Hofmann
18 Jan 2023 via Fresenius Immobilien-Verwaltungs-GmbH & Co. Objekt Friedberg 2 KG
Limited Partner: Fresenius Immobilien-Verwaltungs-GmbH & Co. Objekt Friedberg 2 KG
31 Dec 2022
Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
2 Nov 2022
Officer: Anna Lena Lieblein, Christian Pawlu
7 Sept 2022
No longer Officer: Sara Lisa Hennicken
5 Jul 2022
Con­vert­ible bonds
9 Jun 2022
Capital: €563.2M
2 Jun 2022
List of board members
27 May 2022
Annual report
17 May 2022
Annual report for the year ending 31/12/2021
13 May 2022
Company statute
26 Apr 2022
Consolidated Annual report for the year ending 31/12/2021
21 Apr 2022
Annual report for the year ending 31/12/2021
24 Feb 2022
Capital: €558.5M
24 Feb 2022
List of board members
22 Feb 2022
Shareholder: Harris Associates LP
31 Dec 2021
Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
11 Nov 2021
Officer: Andreas Neukam, Jennifer Weihs
12 Jul 2021
Annual report for the year ending 31/12/2020
8 Jul 2021
Annual report
24 Jun 2021
Consolidated Annual report for the year ending 31/12/2020
11 Jun 2021
Company statute
9 Jun 2021
Annual report for the year ending 31/12/2020
8 Jun 2021
List of board members
1 Jun 2021
Wordmark: Duomix
1 Jun 2021
Wordmark: Sondomat
31 May 2021
Company statute
31 May 2021
Company statute
1 Apr 2021
Wordmark: Infustop
29 Mar 2021
Officer: Wolfgang Hofmann
5 Feb 2021
Capital: €557.5M
29 Jan 2021
Consolidated Annual report for the year ending 31/12/2019
31 Dec 2020
Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
1 Oct 2020
Wordmark: Plasmasteril
10 Sept 2020
Company statute
7 Aug 2020
No longer Officer (1) · List of board members
1 Aug 2020
Wordmark: Teta
16 Jul 2020
No longer Officer (1)
22 Jun 2020
Company statute
15 Jun 2020
Officer (4)
1 May 2020
Word figurative mark
27 Apr 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (2,663 companies)
15 Apr 2020
Annual report
7 Apr 2020
Consolidated Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
3 Feb 2020
No longer Officer (1)
3 Feb 2020
Capital: €557.4M
31 Dec 2019
Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
27 Sept 2019 via Degroof Petercam Asset Management SA, Zweigniederlassung Deutschland
Shareholder: Degroof Petercam Asset Management SA, Zweigniederlassung Deutschland
13 Sept 2019
Shareholder: BlackRock Inc
22 Aug 2019
Officer (3) · No longer Officer (1)
12 Jul 2019
No longer Officer (2)
27 May 2019
Annual report for the year ending 31/12/2018
14 May 2019
Company statute
25 Apr 2019
Annual report
25 Apr 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings (2,523 companies)
15 Apr 2019
Consolidated Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
22 Jan 2019
Capital: €556.2M
31 Dec 2018
Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
27 Dec 2018
Consolidated Annual report for the year ending 31/12/2017
1 Nov 2018
Wordmark: Ultraflow
1 Oct 2018
Wordmark: Endosteril
8 Aug 2018
No longer Officer (1)
2 Jul 2018
Annual report for the year ending 31/12/2017
18 Jun 2018
Con­vert­ible bonds
24 May 2018
Officer: Tjerk Schlufter · No longer Officer (1)
1 May 2018
Wordmark: MAPstain
24 Apr 2018
Company statute
24 Apr 2018
Consolidated Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
16 Feb 2018
Capital: €554.7M
31 Dec 2017
Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
12 Jul 2017
Annual report for the year ending 31/12/2016
30 May 2017 via Allianz Lebensversicherungs-AG, also 05/07/2016, 02/12/2014, 16/09/2013, 27/08/2013
Shareholder: Allianz Lebensversicherungs-AG
24 May 2017
Company statute
11 May 2017
Company statute
1 May 2017
Wordmark: Cavatheter
21 Apr 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (2,302 companies)
11 Apr 2017
Consolidated Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
13 Mar 2017
Capital: €553.3M
31 Jan 2017
Capital: €551.8M
31 Dec 2016
Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
Year 2016 in Dm
5 trademark filings (4 wordmarks, 1 word figurative mark): Fresulac, Imotrans, Longasteril, Traumasteril …
21 Jul 2016
Consolidated Annual report for the year ending 31/12/2015
30 May 2016
Officer (2)
18 May 2016
Company statute
20 Apr 2016
Consolidated Annual report · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (20 companies)
12 Apr 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (2,187 companies)
18 Mar 2016
Officer (1)
17 Feb 2016
Capital: €545.7M
31 Dec 2015
Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
7 Sept 2015
No longer Officer (1)
3 Sept 2015
Shareholder: Henderson Group Holdings Asset Management Ltd
3 Sept 2015
Shareholder: HGI Asset Management Group Ltd
3 Sept 2015
Shareholder: Henderson Global Group Ltd
3 Sept 2015
Shareholder: Henderson Holdings Group Ltd
3 Sept 2015
Shareholder: Janus Henderson UK (Holdings) Ltd
29 Jul 2015
Officer: Markus Georgi
22 Jun 2015
List of board members
22 Jun 2015
List of board members
18 Jun 2015
Annual report for the year ending 31/12/2014
8 Jun 2015 via RHÖN-KLINIKUM AG
Annual report · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (36 companies)
20 May 2015
Company statute
30 Apr 2015
Consolidated Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (9 companies)
13 Apr 2015
No longer Officer (1)
27 Feb 2015
Shareholder: Henderson Global Investors (Holdings) Ltd
27 Feb 2015
Shareholder: Janus Henderson Investors UK Ltd
4 Feb 2015
Capital: €541.5M
31 Dec 2014
Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
20 Oct 2014
No longer Officer (1)
1 Aug 2014
Capital: €540.5M · Company statute
1 Aug 2014
On the basis of the conditional capital resolved at the Annual General Meeting on 04.12.2006 with amendment of …
1 Aug 2014
Con­vert­ible bonds
1 Jul 2014 via Fresenius Konzernfinanzierung Erste GmbH
Shareholding: Fresenius Konzernfinanzierung Erste GmbH
1 Jul 2014 via Fresenius Konzernfinanzierung Zweite GmbH
Shareholding: Fresenius Konzernfinanzierung Zweite GmbH
1 Jul 2014
Wordmark: Ortho-Pract
19 May 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (1,742 companies)
19 May 2014
Consolidated Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (1,752 companies)
7 Mar 2014
Company statute
24 Feb 2014
Capital: €179.7M
16 Jan 2014
No longer Officer (1)
31 Dec 2013
Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
12 Nov 2013
Rechtsform: Die Hauptversammlung vom 17.05.2013 hat die Ergänzung des § 4 um einen neuen Abs. 8 beschlossen
20 Sept 2013
Company statute
9 Aug 2013
Consolidated Annual report for the year ending 31/12/2012
7 Jun 2013
Die Hauptversammlung vom 17.05.2013 hat die Änderung des § 4 (Abs. 4) (Höhe und Einteilung des Grundkapitals…
16 Apr 2013
Consolidated Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (1,681 companies)
12 Apr 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (1,667 companies)
21 Mar 2013
Officer (2)
14 Mar 2013
Officer (1)
14 Mar 2013
No longer Officer (2) · Officer (2)
14 Mar 2013
Capital: €178.2M
31 Dec 2012
Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
13 Dec 2012
Company statute
1 Nov 2012
Officer (1)
9 Aug 2012
No longer Officer (1)
5 Jul 2012
The Annual General Meeting on 11.05.2012 resolved to amend § 4 (share capital).
21 Jun 2012
Antitrust Investigation: Fresenius SE & Co. KGaA, Rhön-Klinikum AG
21 Jun 2012
Antitrust Investigation: Fresenius SE & Co. KGaA, Rhön-Klinikum AG
31 May 2012
Consolidated Annual report for the year ending 31/12/2011
18 May 2012
Company statute
18 May 2012
Capital: €177M
10 May 2012
Company statute
1 May 2012
Wordmark: Jonozell
19 Apr 2012
Officer: Ulf Freytag · No longer Officer (1)
19 Apr 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings (1,246 companies)
12 Apr 2012
Consolidated Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings (1,247 companies)
1 Mar 2012
Registration lfd. No …
23 Feb 2012
Capital: €163.2M
24 Jan 2012
Berichtigt, nun: Die persönlich haftende Gesellschafterin ist durch Beschluss der Hauptversammlung vom 13.05.2011…
12 Jan 2012
Additionally entered to registration lfd. No …
31 Dec 2011
Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
14 Jul 2011
Company statute
30 Jun 2011
Annual report for the year ending 31/12/2010
1 Jun 2011
List of board members
29 Mar 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings (1,113 companies)
28 Mar 2011
Consolidated Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
10 Feb 2011
Officer (12) · General partner: Fresenius Management SE · Change of legal form: Fresenius SE · Address · Capital: €162.5M · Proxy · Corporate Purpose
10 Feb 2011 as Fresenius SE
Change of legal form: Fresenius SE
10 Feb 2011 via Fresenius Medical Care AG & Co. KGaA
Shareholding: Fresenius Medical Care AG & Co. KGaA
28 Jan 2011
Reg­is­tra­tion · Officer (12) · General partner: Fresenius Management SE · Legal form: KGaA · Name: Fresenius SE & Co. KGaA · Corporate Purpose

Mentions

in Ler
Direct parent (36 companies) · No longer Direct parent (3 companies)
in Ler
Ultimate parent (96 companies) · No longer Ultimate parent (3 companies)
via Companies House in Psc
VR: Hermed Biomedical Engineering UK Ltd., Fresenius Kabi Oncology PLC, Avensys UK Group Ltd. · BO: Hermed Biomedical Engineering UK Ltd. …
in Ler
Ultimate parent (128 companies)
in Ler
Direct parent (78 companies)

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Fresenius SE & Co. KGaA, Bad Homburg v. d. Höhe, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license. Creative Commons License Les visualisations de "Fresenius SE & Co. KGaA, Bad Homburg v. d. Höhe, Germany" sont mis à disposition par North Data et peuvent être réutilisées selon les termes de la licence Creative Commons CC-BY.

Printing is only available to North Data premium service subscribers.
Close